Try our Advanced Search for more refined results

Citizens for Consume, et al v. Abbott Laboratories,, et al

Track this case

Case Number:

1:01-cv-12257

Court:

Nature of Suit:

Multi Party Litigation:

Class Action

Judge:

Firms

Companies

Government Agencies

Sectors & Industries:

July 10, 2007
AstraZeneca, Bristol-Myers Oppose "Do Over"

AstraZeneca LP and Bristol Myers-Squibb Co. have asked a judge to reject plaintiffs' request that the court award them an additional year's worth of damages, pointing out that the group's earlier quest to prove the degree of alleged harm had already failed.
July 06, 2007
Wholesale Price Plaintiffs Call Damages Incomplete

After winning damages for harm suffered from 1997 through 2002 in a massive antitrust class action against several pharmaceutical giants, plaintiffs asked the court Thursday to award damages for 2003 as well, though there is no hard data showing harm in that year.
June 29, 2007
Dey Buries Hatchet With States In Drug Pricing Suit

The states of Montana and Nevada have reached a settlement with Dey Inc., one of a slew of pharmaceutical companies involved in a massive antitrust class action alleging that the companies defrauded consumers by artificially inflating the prices of various prescription drugs.
June 21, 2007
Judge Finds Drug Makers Liable For Inflating Costs

A federal judge has issued a stinging rebuke to three pharmaceutical companies in a massive antitrust class action, finding that they acted unfairly and deceptively by causing the publication of artificially inflated average wholesale prices for various prescription drugs.
June 20, 2007
Plaintiffs Win More Time To Seal Glaxo Deal

The plaintiffs in an antitrust class action alleging that a slew of pharmaceutical companies defrauded consumers by artificially inflating the prices of various prescription drugs have received more time to finalize a settlement with GlaxoSmithKline plc.
November 03, 2006
Pharmaceutical Giants, Consumers Spar As Trial Looms

On the eve of trial, a federal judge has clarified the definition of a term at the center of an antitrust class action lawsuit alleging that a slew of pharmaceutical companies defrauded consumers by artificially inflating the prices of various prescription drugs.
September 11, 2006
DOJ Joins Whistleblower Suit Against Merck Affiliate

The U.S. Department of Justice said Monday that it has intervened in a whistleblower lawsuit accusing generic drug maker Dey Inc., an affiliate of German pharmaceutical company Merck KGaA, of engaging in a fraudulent scheme to overcharge federal health care programs.

← Previous
1
2
3
4
Next →